Do analysts prefer ICU or ZYXI?

SeaStar Medical currently has a consensus price target of $8.00, suggesting a potential upside of 150.78%. Given SeaStar Medical's stronger consensus rating and higher possible upside, research analysts plainly believe SeaStar Medical is more favorable than Zynex. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SeaStar Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Zynex 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings and valuation, ICU or ZYXI?

Zynex has higher revenue and earnings than SeaStar Medical. SeaStar Medical is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio SeaStar Medical $1.23M 11.44 -$12.15M -$3.91 N/A Zynex $108.20M 0.04 $2.99M -$2.43 N/A

Is ICU or ZYXI more profitable?

Zynex has a net margin of -68.35% compared to SeaStar Medical's net margin of -795.51%. SeaStar Medical's return on equity of -162.75% beat Zynex's return on equity. Company Net Margins Return on Equity Return on Assets SeaStar Medical -795.51% -162.75% -109.89% Zynex -68.35% -804.30% -36.67%

Do analysts recommend ADGM or ZYXI?

Adagio Medical presently has a consensus target price of $3.50, suggesting a potential upside of 493.12%. Given Adagio Medical's stronger consensus rating and higher possible upside, research analysts clearly believe Adagio Medical is more favorable than Zynex. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adagio Medical 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Zynex 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings & valuation, ADGM or ZYXI?

Zynex has higher revenue and earnings than Adagio Medical. Adagio Medical is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Adagio Medical $600K 21.84 -$25.08M -$1.48 N/A Zynex $108.20M 0.04 $2.99M -$2.43 N/A

Is ADGM or ZYXI more profitable?

Adagio Medical has a net margin of 0.00% compared to Zynex's net margin of -68.35%. Adagio Medical's return on equity of -661.85% beat Zynex's return on equity. Company Net Margins Return on Equity Return on Assets Adagio Medical N/A -661.85% -73.35% Zynex -68.35% -804.30% -36.67%

Do analysts prefer MBAI or ZYXI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Check-Cap 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Zynex 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is MBAI or ZYXI more profitable?

Check-Cap has a net margin of 0.00% compared to Zynex's net margin of -68.35%. Check-Cap's return on equity of 0.00% beat Zynex's return on equity. Company Net Margins Return on Equity Return on Assets Check-Cap N/A N/A N/A Zynex -68.35% -804.30% -36.67%

Do analysts recommend ICCM or ZYXI?

IceCure Medical presently has a consensus price target of $52.50, suggesting a potential upside of 2,212.78%. Given IceCure Medical's stronger consensus rating and higher probable upside, research analysts plainly believe IceCure Medical is more favorable than Zynex. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IceCure Medical 2 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.20 Zynex 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation & earnings, ICCM or ZYXI?

Zynex has higher revenue and earnings than IceCure Medical. IceCure Medical is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IceCure Medical $3.38M 2.30 -$15.06M -$8.52 N/A Zynex $108.20M 0.04 $2.99M -$2.43 N/A

Is ICCM or ZYXI more profitable?

Zynex has a net margin of -68.35% compared to IceCure Medical's net margin of -427.67%. IceCure Medical's return on equity of -174.26% beat Zynex's return on equity. Company Net Margins Return on Equity Return on Assets IceCure Medical -427.67% -174.26% -112.58% Zynex -68.35% -804.30% -36.67%

Do analysts recommend HSCS or ZYXI?

HeartSciences presently has a consensus target price of $8.00, suggesting a potential upside of 189.86%. Given HeartSciences' stronger consensus rating and higher possible upside, research analysts plainly believe HeartSciences is more favorable than Zynex. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HeartSciences 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Zynex 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is HSCS or ZYXI more profitable?

HeartSciences has a net margin of 0.00% compared to Zynex's net margin of -68.35%. HeartSciences' return on equity of -358.60% beat Zynex's return on equity. Company Net Margins Return on Equity Return on Assets HeartSciences N/A -358.60% -144.82% Zynex -68.35% -804.30% -36.67%

Zynex (ZYXI) Competitors

$0.12 0.00 (0.00%)

As of 08/21/2026

Compare

ZYXI vs. ICU, ADGM, MBAI, ICCM, and HSCS

Should you buy Zynex stock or one of its competitors? Zynex's main competitors and comparable companies include SeaStar Medical (ICU), Adagio Medical (ADGM), Check-Cap (MBAI), IceCure Medical (ICCM), and HeartSciences (HSCS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Zynex compare to SeaStar Medical?

SeaStar Medical (NASDAQ:ICU) and Zynex (NASDAQ:ZYXI) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, media sentiment, analyst recommendations, institutional ownership, dividends, valuation and profitability.

SeaStar Medical currently has a consensus price target of $8.00, suggesting a potential upside of 150.78%. Given SeaStar Medical's stronger consensus rating and higher possible upside, research analysts plainly believe SeaStar Medical is more favorable than Zynex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SeaStar Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Zynex	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Zynex has a net margin of -68.35% compared to SeaStar Medical's net margin of -795.51%. SeaStar Medical's return on equity of -162.75% beat Zynex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SeaStar Medical	-795.51%	-162.75%	-109.89%
Zynex	-68.35%	-804.30%	-36.67%

In the previous week, SeaStar Medical had 5 more articles in the media than Zynex. MarketBeat recorded 5 mentions for SeaStar Medical and 0 mentions for Zynex. Zynex's average media sentiment score of 0.00 beat SeaStar Medical's score of -0.20 indicating that Zynex is being referred to more favorably in the news media.

Company	Overall Sentiment
SeaStar Medical	Neutral
Zynex	Neutral

1.7% of SeaStar Medical shares are held by institutional investors. Comparatively, 29.7% of Zynex shares are held by institutional investors. 0.7% of SeaStar Medical shares are held by company insiders. Comparatively, 49.3% of Zynex shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Zynex has higher revenue and earnings than SeaStar Medical. SeaStar Medical is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SeaStar Medical	$1.23M	11.44	-$12.15M	-$3.91	N/A
Zynex	$108.20M	0.04	$2.99M	-$2.43	N/A

SeaStar Medical has a beta of -1.05, indicating that its stock price is 205% less volatile than the broader market. Comparatively, Zynex has a beta of 0.99, indicating that its stock price is 1% less volatile than the broader market.

Summary

Zynex beats SeaStar Medical on 10 of the 16 factors compared between the two stocks.

How does Zynex compare to Adagio Medical?

Adagio Medical (NASDAQ:ADGM) and Zynex (NASDAQ:ZYXI) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, dividends, profitability, earnings, analyst recommendations, risk and valuation.

48.1% of Adagio Medical shares are held by institutional investors. Comparatively, 29.7% of Zynex shares are held by institutional investors. 7.8% of Adagio Medical shares are held by insiders. Comparatively, 49.3% of Zynex shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Zynex has higher revenue and earnings than Adagio Medical. Adagio Medical is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Adagio Medical	$600K	21.84	-$25.08M	-$1.48	N/A
Zynex	$108.20M	0.04	$2.99M	-$2.43	N/A

Adagio Medical has a beta of -0.15, suggesting that its stock price is 115% less volatile than the broader market. Comparatively, Zynex has a beta of 0.99, suggesting that its stock price is 1% less volatile than the broader market.

Adagio Medical presently has a consensus target price of $3.50, suggesting a potential upside of 493.12%. Given Adagio Medical's stronger consensus rating and higher possible upside, research analysts clearly believe Adagio Medical is more favorable than Zynex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adagio Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Zynex	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Adagio Medical has a net margin of 0.00% compared to Zynex's net margin of -68.35%. Adagio Medical's return on equity of -661.85% beat Zynex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Adagio Medical	N/A	-661.85%	-73.35%
Zynex	-68.35%	-804.30%	-36.67%

In the previous week, Adagio Medical's average media sentiment score of 0.00 equaled Zynex'saverage media sentiment score.

Company	Overall Sentiment
Adagio Medical	Neutral
Zynex	Neutral

Summary

Adagio Medical beats Zynex on 8 of the 14 factors compared between the two stocks.

How does Zynex compare to Check-Cap?

Check-Cap (NASDAQ:MBAI) and Zynex (NASDAQ:ZYXI) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, institutional ownership, risk, media sentiment, dividends, analyst recommendations and profitability.

Check-Cap has a beta of 0.68, meaning that its share price is 32% less volatile than the broader market. Comparatively, Zynex has a beta of 0.99, meaning that its share price is 1% less volatile than the broader market.

Check-Cap has a net margin of 0.00% compared to Zynex's net margin of -68.35%. Check-Cap's return on equity of 0.00% beat Zynex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Check-Cap	N/A	N/A	N/A
Zynex	-68.35%	-804.30%	-36.67%

In the previous week, Check-Cap had 1 more articles in the media than Zynex. MarketBeat recorded 1 mentions for Check-Cap and 0 mentions for Zynex. Check-Cap's average media sentiment score of 0.00 equaled Zynex'saverage media sentiment score.

Company	Overall Sentiment
Check-Cap	Neutral
Zynex	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Check-Cap	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Zynex	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Check-Cap has higher earnings, but lower revenue than Zynex. Check-Cap is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Check-Cap	N/A	N/A	$4.14M	-$14.07	N/A
Zynex	$108.20M	0.04	$2.99M	-$2.43	N/A

1.1% of Check-Cap shares are held by institutional investors. Comparatively, 29.7% of Zynex shares are held by institutional investors. 0.5% of Check-Cap shares are held by company insiders. Comparatively, 49.3% of Zynex shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Zynex beats Check-Cap on 6 of the 11 factors compared between the two stocks.

How does Zynex compare to IceCure Medical?

IceCure Medical (NASDAQ:ICCM) and Zynex (NASDAQ:ZYXI) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, profitability, institutional ownership, analyst recommendations, dividends, media sentiment and earnings.

IceCure Medical has a beta of 0.47, indicating that its stock price is 53% less volatile than the broader market. Comparatively, Zynex has a beta of 0.99, indicating that its stock price is 1% less volatile than the broader market.

IceCure Medical presently has a consensus price target of $52.50, suggesting a potential upside of 2,212.78%. Given IceCure Medical's stronger consensus rating and higher probable upside, research analysts plainly believe IceCure Medical is more favorable than Zynex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IceCure Medical	2 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.20
Zynex	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Zynex has a net margin of -68.35% compared to IceCure Medical's net margin of -427.67%. IceCure Medical's return on equity of -174.26% beat Zynex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IceCure Medical	-427.67%	-174.26%	-112.58%
Zynex	-68.35%	-804.30%	-36.67%

In the previous week, IceCure Medical had 3 more articles in the media than Zynex. MarketBeat recorded 3 mentions for IceCure Medical and 0 mentions for Zynex. Zynex's average media sentiment score of 0.00 beat IceCure Medical's score of -0.33 indicating that Zynex is being referred to more favorably in the news media.

Company	Overall Sentiment
IceCure Medical	Neutral
Zynex	Neutral

0.6% of IceCure Medical shares are owned by institutional investors. Comparatively, 29.7% of Zynex shares are owned by institutional investors. 2.4% of IceCure Medical shares are owned by insiders. Comparatively, 49.3% of Zynex shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Zynex has higher revenue and earnings than IceCure Medical. IceCure Medical is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IceCure Medical	$3.38M	2.30	-$15.06M	-$8.52	N/A
Zynex	$108.20M	0.04	$2.99M	-$2.43	N/A

Summary

Zynex beats IceCure Medical on 10 of the 16 factors compared between the two stocks.

How does Zynex compare to HeartSciences?

HeartSciences (NASDAQ:HSCS) and Zynex (NASDAQ:ZYXI) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, dividends, profitability, media sentiment, valuation, institutional ownership, analyst recommendations and earnings.

HeartSciences presently has a consensus target price of $8.00, suggesting a potential upside of 189.86%. Given HeartSciences' stronger consensus rating and higher possible upside, research analysts plainly believe HeartSciences is more favorable than Zynex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HeartSciences	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Zynex	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

17.2% of HeartSciences shares are owned by institutional investors. Comparatively, 29.7% of Zynex shares are owned by institutional investors. 4.9% of HeartSciences shares are owned by company insiders. Comparatively, 49.3% of Zynex shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

HeartSciences has a beta of 1.79, indicating that its stock price is 79% more volatile than the broader market. Comparatively, Zynex has a beta of 0.99, indicating that its stock price is 1% less volatile than the broader market.

In the previous week, HeartSciences had 4 more articles in the media than Zynex. MarketBeat recorded 4 mentions for HeartSciences and 0 mentions for Zynex. HeartSciences' average media sentiment score of 0.18 beat Zynex's score of 0.00 indicating that HeartSciences is being referred to more favorably in the media.

Company	Overall Sentiment
HeartSciences	Neutral
Zynex	Neutral

HeartSciences has a net margin of 0.00% compared to Zynex's net margin of -68.35%. HeartSciences' return on equity of -358.60% beat Zynex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HeartSciences	N/A	-358.60%	-144.82%
Zynex	-68.35%	-804.30%	-36.67%

Zynex has higher revenue and earnings than HeartSciences. HeartSciences is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HeartSciences	N/A	N/A	-$9.14M	-$3.94	N/A
Zynex	$108.20M	0.04	$2.99M	-$2.43	N/A

Summary

HeartSciences beats Zynex on 8 of the 15 factors compared between the two stocks.

Get Zynex News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ZYXI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ZYXI vs. The Competition

Export

Metric	Zynex	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$3.80M	$5.98B	$7.36B	$12.81B
Dividend Yield	N/A	1.74%	2.53%	10.78%
P/E Ratio	-0.05	26.04	270.55	24.05
Price / Sales	0.04	71.09	630.76	95.90
Price / Cash	0.51	33.71	29.03	36.89
Price / Book	0.11	6.18	11.18	6.40
Net Income	$2.99M	$149.30M	$3.46B	$347.95M
7 Day Performance	N/A	0.89%	1.98%	0.91%
1 Month Performance	N/A	8.83%	7.32%	5.10%
1 Year Performance	-92.47%	7.23%	24.76%	16.16%

Zynex Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ZYXI Zynex	N/A	$0.13 flat	N/A	N/A	$3.80M	$108.20M	N/A	770
ICU SeaStar Medical	3.3153 of 5 stars	$3.34 +2.8%	$8.00 +139.5%	-58.1%	$14.73M	$1.23M	N/A	2	Analyst Downgrade
ADGM Adagio Medical	2.0186 of 5 stars	$0.65 -0.8%	$3.50 +441.8%	-49.7%	$14.35M	N/A	N/A	87
MBAI Check-Cap	0.1391 of 5 stars	$8.36 +4.2%	N/A	N/A	$11.30M	N/A	N/A	80
ICCM IceCure Medical	2.8944 of 5 stars	$2.60 -7.8%	$52.50 +1,919.2%	-90.8%	$8.92M	$3.38M	N/A	60

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ZYXI) was last updated on 8/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Zynex (ZYXI) Competitors

ZYXI vs. ICU, ADGM, MBAI, ICCM, and HSCS

How does Zynex compare to SeaStar Medical?

Summary

How does Zynex compare to Adagio Medical?

Summary

How does Zynex compare to Check-Cap?

Summary

How does Zynex compare to IceCure Medical?

Summary

How does Zynex compare to HeartSciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ZYXI vs. The Competition

Zynex Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Zynex (ZYXI) Competitors

ZYXI vs. ICU, ADGM, MBAI, ICCM, and HSCS

How does Zynex compare to SeaStar Medical?

Do analysts prefer ICU or ZYXI?

Is ICU or ZYXI more profitable?

Does the media refer more to ICU or ZYXI?

Do insiders & institutionals hold more shares of ICU or ZYXI?

Which has higher earnings and valuation, ICU or ZYXI?

Which has more risk & volatility, ICU or ZYXI?

Summary

How does Zynex compare to Adagio Medical?

Do insiders and institutionals believe in ADGM or ZYXI?

Which has preferable earnings & valuation, ADGM or ZYXI?

Which has more volatility & risk, ADGM or ZYXI?

Do analysts recommend ADGM or ZYXI?

Is ADGM or ZYXI more profitable?

Does the media favor ADGM or ZYXI?

Summary

How does Zynex compare to Check-Cap?

Which has more risk & volatility, MBAI or ZYXI?

Is MBAI or ZYXI more profitable?

Does the media favor MBAI or ZYXI?

Do analysts prefer MBAI or ZYXI?

Which has preferable valuation and earnings, MBAI or ZYXI?

Do insiders & institutionals believe in MBAI or ZYXI?

Summary

How does Zynex compare to IceCure Medical?

Which has more risk & volatility, ICCM or ZYXI?

Do analysts recommend ICCM or ZYXI?

Is ICCM or ZYXI more profitable?

Does the media prefer ICCM or ZYXI?

Do insiders and institutionals hold more shares of ICCM or ZYXI?

Which has preferable valuation & earnings, ICCM or ZYXI?

Summary

How does Zynex compare to HeartSciences?

Do analysts recommend HSCS or ZYXI?

Do insiders & institutionals hold more shares of HSCS or ZYXI?

Which has more volatility & risk, HSCS or ZYXI?

Does the media prefer HSCS or ZYXI?

Is HSCS or ZYXI more profitable?

Which has stronger valuation and earnings, HSCS or ZYXI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ZYXI vs. The Competition

Zynex Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools